Zobrazeno 1 - 10
of 1 374
pro vyhledávání: '"intravesical instillation"'
Publikováno v:
Investigative and Clinical Urology, Vol 65, Iss 5, Pp 435-441 (2024)
Purpose: In high-risk non-muscle-invasive bladder cancer (NMIBC), intravesical Bacillus Calmette-Guérin (BCG) is the standard adjuvant therapy post-transurethral resection of bladder tumor (TURBT). Intravesical gemcitabine, used as an alternative or
Externí odkaz:
https://doaj.org/article/3db1a257176c4897bb62813312846c11
Autor:
Goran Rac, Hiten D. Patel, Christopher James, Shalin Desai, Vincent M. Caruso, Daniel S. Fischer, Peter S. Lentz, Ceressa T. Ward, Brian C. Mazzarella, Kevin G. Phillips, Chirag Doshi, Vincent T. Bicocca, Trevor G. Levin, Alan J. Wolfe, Gopal N. Gupta
Publikováno v:
Molecular Oncology, Vol 18, Iss 2, Pp 291-304 (2024)
Intravesical therapy (IVT) is the standard of care to decrease risk of recurrence and progression for high‐grade nonmuscle‐invasive bladder cancer. However, post‐IVT recurrence remains common and the ability to risk‐stratify patients before o
Externí odkaz:
https://doaj.org/article/d353b6be5cfb4f84b1c4d2ba8274a89c
Autor:
Gere S. diZerega, Holly A. Maulhardt, Shelagh J. Verco, Alyson M. Marin, Michael J. Baltezor, Samantha A. Mauro, Marc A. Iacobucci
Publikováno v:
Oncology and Therapy, Vol 12, Iss 1, Pp 31-55 (2024)
Abstract This review summarizes development of large surface area microparticle paclitaxel (LSAM-PTX) and docetaxel (LSAM-DTX) for local treatment of primary carcinomas with emphasis on immunomodulation. Intratumoral (IT) delivery of LSAM-PTX and LSA
Externí odkaz:
https://doaj.org/article/7de53546cb374c4996224b668fc861da
Autor:
Fangming Wang, Gang Zhang, Tianli Xu, Jianlin Ma, Jing Wang, Shuai Liu, Yuzhe Tang, Song Jin, Jianxing Li, Nianzeng Xing
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)
Abstract Background Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or Bacillus Calmette–Guérin therapy. However, these treatments ha
Externí odkaz:
https://doaj.org/article/e4f3e864202040dfa8c38512735bcf7e
Autor:
Sławomir Poletajew, Magdalena M. Brzózka, Wojciech Krajewski, Hubert Kamecki, Łukasz Nyk, Piotr Kryst
Publikováno v:
Pain and Therapy, Vol 13, Iss 1, Pp 1-22 (2023)
Abstract Defects in the glycosaminoglycan layer (GAG) of the bladder mucosa have been identified as a significant contributor to the pathogenesis and clinical progression of chronic inflammatory diseases of the bladder, such as post-radiation cystiti
Externí odkaz:
https://doaj.org/article/93f3299f913f46a3a7fddd4f2c18ed3e
Publikováno v:
Xin yixue, Vol 54, Iss 9, Pp 629-633 (2023)
Bladder cancer is the most common malignant tumor of the urinary system， which seriously affects patients’ health and life. Transurethral resection of bladder tumor is the main treatment for non-muscle invasive bladder cancer （NMIBC）， where
Externí odkaz:
https://doaj.org/article/80884f4058194a58b17b982019d91aa2
Autor:
Hikaru Tomoe
Publikováno v:
Continence, Vol 8, Iss , Pp 101058- (2023)
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a refractory chronic cystitis of unknown origin. The intravesical instillation therapy of Dimethyl sulfoxide (DMSO) for IC/BPS was approved by the FDA in 1978, and there are reports showing its
Externí odkaz:
https://doaj.org/article/5f877ee1e3d5454e9010119fb599eaa7
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 227-237 (2023)
Nadia Quignot,1 Heng Jiang,1 Indraraj Umesh Doobaree,2 Jan Lehmann,3 Ola Ghatnekar4 1Evidence & Access, Certara France, Paris, France; 2Evidence & Access, Certara UK, Sheffield, UK; 3Department of Urology, Städtisches Krankenhaus, Kiel, Germany; 4Fe
Externí odkaz:
https://doaj.org/article/0db6a58dd6354cfd8536ade6421d7671
Autor:
Laura S. Mertens, Vidit Sharma, Surena F. Matin, Stephen A. Boorjian, R. Houston Thompson, Bas W.G. van Rhijn, Alexandra Masson-Lecomte
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 60-66 (2023)
Context: Bladder recurrences have been reported in 22–47% of patients after surgery for upper urinary tract urothelial carcinoma (UTUC). This collaborative review focuses on risk factors for and treatment strategies to reduce bladder recurrences af
Externí odkaz:
https://doaj.org/article/55afe1942a124e5f8c56e80e6cd9c8da
Autor:
Xuwei Hong, Xu Chen, Hongjin Wang, Qingchun Xu, Kanghua Xiao, Yuanfeng Zhang, Zepai Chi, Yeqing Liu, Guangyao Liu, Hong Li, Jianmin Fang, Tianxin Lin, Yonghai Zhang
Publikováno v:
Advanced Science, Vol 10, Iss 32, Pp n/a-n/a (2023)
Abstract More than half of non‐muscle‐invasive bladder cancer (NMIBC) patients eventually relapse even if treated with surgery and BCG without optional bladder‐preserving therapy. This study aims to investigate the antitumor activity and safety
Externí odkaz:
https://doaj.org/article/35a03614143e4a388d5485c73af27f30